SUMO1 抗体
Our Local Distributor
北京 101111
Quick Overview for SUMO1 抗体 (ABIN3026266)
抗原
See all SUMO1 抗体适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
原理
- SUMO1 Antibody (azide and preservative free)
-
纯化方法
- Protein G affinity chromatography
-
免疫原
- Recombinant human protein was used as the immunogen for this SUMO1 antibody.
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
-
Titering of the SUMO1 antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
储存液
- Azide free
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store the SUMO1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))
-
别名
- SUMO1
-
背景
- The small ubiquitin-related modifier (SUMO) proteins, which include SUMO1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability.
-
途径
- M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
抗原
-